DailyDoctor Archive Specialties Get app
Back to the 23 October 2026 edition

Clinical update · 01 of 06

About one in nine B3 lesions on vacuum biopsy is upgraded to malignancy

Report B3 lesions by specific type and atypia status, because the overall upgrade risk of about 11% hides a wide range.

Design
Systematic review and meta-analysis of observational studies
Population
844 B3 breast lesions diagnosed on vacuum-assisted biopsy, five studies
Primary outcome
Upgrade to malignancy on subsequent excision
Effect
Pooled 11.23% (95% CI 7.22–17.04%); prediction interval 4.56–25.06%

A systematic review pooled five full-text studies that followed B3 (uncertain malignant potential) breast lesions diagnosed on vacuum-assisted biopsy. Of 844 lesions, 98 were upgraded to malignancy on excision: a pooled 11.2% (95% CI 7.2–17.0%), with a prediction interval of 4.6–25.1%.

Studies of second-line vacuum-assisted excision reported upgrade rates from 5% to 21%, but these were not pooled because case mix and pathways differed. Certainty was rated very low, and several reports could not be retrieved in full.

For pathologists the message is about the report: a B3 category covers lesions with very different upgrade risks, and multidisciplinary teams need the specific lesion type — atypical ductal hyperplasia, papilloma with or without atypia, radial scar — and whether atypia is present to decide between excision, vacuum excision and surveillance.

  • Name the specific B3 lesion and state whether atypia is present.
  • Bring B3 results to the multidisciplinary meeting with imaging correlation.
  • Expect an upgrade rate of roughly one in nine overall, varying widely by lesion type.
  • Note the sampling method, since vacuum biopsy and vacuum excision carry different meaning.

Why it matters

Surveillance versus excision for B3 lesions turns on detail the pathology report must carry.

Don't overread it

Certainty was very low and only five studies were pooled.

The statistics, in plain English

The prediction interval of 4.6% to 25.1% is the range expected in a new centre, and is wider than the confidence interval because the studies disagreed (I² 61%).

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

surgpathmolecularihcdigitalpathbiomarkers

Tomorrow morning, before your first patient

One edition a day for pathology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app